To ask the Secretary of State for Health, how many medicines approved through the highly specialised technologies programme to date had a budget effect above the threshold proposed in NICE's and NHS England's proposals for changes to the arrangements for evaluating and funding drugs and other health technologies appraised through NICE's technology appraisal and highly specialised technologies programme, published in October 2016.
8 November 2016
The National Institute for Health and Care Excellence (NICE) has advised that it has published final guidance on three highly specialised technologies. Using list prices of these drugs, two would have exceeded the budget impact threshold as defined in the proposals.
The actual budget impact of drugs recommended by NICE in highly specialised technologies guidance may differ from that calculated using the list price as NICE may recommend use subject to any patient access schemes or managed access agreements between the company and NHS England.